The NYMX chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the NYMX chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The NYMX stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
|View NYMX Detailed Price Forecast - CNN Money||View NYMX Detailed Summary - Google Finance|
|View NYMX Detailed Summary - Yahoo! Finance||View NYMX Stock Research & Analysis - Zacks.com|
|View NYMX Trends & Analysis - Trade-Ideas||View NYMX Major Holders - Barrons|
|View NYMX Call Transcripts - NASDAQ||View NYMX Breaking News & Analysis - Seeking Alpha|
|View NYMX Annual Report - CompanySpotlight.com||View NYMX OTC Short Report - OTCShortReport.com|
|View NYMX Fundamentals - TradeKing||View NYMX SEC Filings - Bar Chart|
|View Historical Prices for NYMX - The WSJ||View Performance/Total Return for NYMX - Morningstar|
|View the Analyst Estimates for NYMX - MarketWatch||View the Earnings History for NYMX - CNBC|
|View the NYMX Earnings - StockMarketWatch||View NYMX Buy or Sell Recommendations - MacroAxis|
|View the NYMX Bullish Patterns - American Bulls||View NYMX Short Pain Metrics - ShortPainBot.com|
|View NYMX Stock Mentions - StockTwits||View NYMX Stock Mentions - PennyStockTweets|
|View NYMX Stock Mentions - Twitter||View NYMX Investment Forum News - Investor Hub|
|View NYMX Stock Mentions - Yahoo! Message Board||View NYMX Stock Mentions - Seeking Alpha|
|View Insider Transactions for NYMX - SECform4.com||View Insider Transactions for NYMX - Insider Cow|
|View NYMX Major Holdings Summary - CNBC||View Insider Disclosure for NYMX - OTC Markets|
|View Insider Transactions for NYMX - Yahoo! Finance||View Institutional Holdings for NYMX - NASDAQ|
|View NYMX Stock Insight & Charts - FinViz.com||View NYMX Investment Charts - StockCharts.com|
|View NYMX Stock Overview & Charts - BarChart||View NYMX User Generated Charts - Trading View|
Introducing Nymox Pharmaceutical (NASDAQ:NYMX), The Stock That Slid 60% In The Last Five Years
Posted on Monday March 18, 2019
It is a pleasure to report that the Nymox Pharmaceutical Corporation (NASDAQ:NYMX) is up 36% in the last quarter. But that can't change the reality that over the longer termRead More...
Nymox Announces Appointment of Russell Thomson Ph.D. as Director of Quality and EU Qualified Person for Company's Manufacturing Operations
Posted on Wednesday March 13, 2019
Nymox Pharmaceutical Corporation (NYMX) is pleased to announce the new appointment of Russell I. Thomson PhD, FRSC, as the Company's Director of Quality and EU Qualified Person, for all of Nymox's Chemistry, Manufacturing and Controls Operations. Dr Thomson is an authority in the field of Quality Assurance and Control in the Chemical and Pharmaceutical Industries. Dr. Thomson is a Fellow of the Royal Society of Chemistry (UK), a Chartered Chemist and Chairman of the Royal Society of Chemistry Qualified Persons Assessors Panel. He has worked in the pharmaceutical industry in positions including Head of Quality and Director of QA and Regulatory Affairs, and as Consultant Qualified Person at numerous large and small drug manufacturing facilities in the EU and the US for over 20 years. Dr. Thomson was a Chartered Scientist with The Science Council (UK) from 2004-2010 and Corporate Member of the South African Chemical Institute from 1980-1999.
Nymox to Host Investor Teleconference
Posted on Monday March 11, 2019
Management will discuss the Company's current business progress with an update on its regulatory submission activities in the US and EU. To the extent that statements contained in this press release are not descriptions of historical facts regarding Nymox, they are forward-looking statements reflecting the current beliefs and expectations of management made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, including statements regarding the need for new options to treat BPH and prostate cancer, the potential of Fexapotide to treat BPH and prostate cancer and the estimated timing of further developments for Fexapotide. Such forward-looking statements involve substantial risks and uncertainties that could cause our clinical development program, future results, performance or achievements to differ significantly from those expressed or implied by the forward-looking statements.
Does The Nymox Pharmaceutical Corporation (NASDAQ:NYMX) Share Price Fall With The Market?
Posted on Wednesday January 30, 2019
If you own shares in Nymox Pharmaceutical Corporation (NASDAQ:NYMX) then it's worth thinking about how it contributes to the volatility of your portfolio, overall. In finance, Beta is a measure Read More...